Related references
Note: Only part of the references are listed.Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer
Jinxiu Guo et al.
FRONTIERS IN ONCOLOGY (2021)
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balazs Gyorffy
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
Yota Yasumizu et al.
NATURE COMMUNICATIONS (2020)
MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment
Donald W. Kufe
CARCINOGENESIS (2020)
Role of Mitochondria in Cancer Stem Cell Resistance
Jose Manuel Garcia-Heredia et al.
CELLS (2020)
Succinyl-CoA Ligase Deficiency in Pro-inflammatory and Tissue-Invasive T Cells
Bowen Wu et al.
CELL METABOLISM (2020)
The role of the EGFR signaling pathway in stem cell differentiation during planarian regeneration and homeostasis
Sara Barberan et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers
Daisong Wang et al.
CELL RESEARCH (2019)
Rescue of TCA Cycle Dysfunction for Cancer Therapy
Jubert Marquez et al.
JOURNAL OF CLINICAL MEDICINE (2019)
EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1
H. J. Cho et al.
ONCOGENE (2018)
MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer
Yuan Li et al.
ONCOTARGET (2018)
MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells
Hasan Rajabi et al.
ONCOGENE (2018)
Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
Zhengqiu Zhou et al.
ANTIOXIDANTS (2018)
Mitochondrial DNA maintenance defects
Ayman W. El-Hattab et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors
M. R. Schneider et al.
ONCOGENE (2016)
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis
Marjolein J. A. Weerts et al.
ONCOTARGET (2016)
Mechanisms of lapatinib resistance in HER2-driven breast cancer
Valentina D'Amato et al.
CANCER TREATMENT REVIEWS (2015)
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
Michalina Janiszewska et al.
NATURE GENETICS (2015)
MUC1: A novel metabolic master regulator
Kamiya Mehla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Mammary stem cells and the differentiation hierarchy: current status and perspectives
Jane E. Visvader et al.
GENES & DEVELOPMENT (2014)
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
Seyung S. Chung et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
D. Raina et al.
ONCOGENE (2014)
How pregnancy at early age protects against breast cancer
Fabienne Meier-Abt et al.
TRENDS IN MOLECULAR MEDICINE (2014)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
Maroof Alam et al.
ONCOTARGET (2014)
Targeting ERBB Receptors Shifts Their Partners and Triggers Persistent ERK Signaling through a Novel ERBB/EFNB1 Complex
Paola D. Vermeer et al.
CANCER RESEARCH (2013)
MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells
Hirotomo Tanaka et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
D. W. Kufe
ONCOGENE (2013)
Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
Ariella B. Hanker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family
Anton Arkhipov et al.
ELIFE (2013)
How to calculate sample size in animal studies?
Jaykaran Charan et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Andrew R. Mullen et al.
NATURE (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of β-Catenin
Yuan Li et al.
PLOS ONE (2011)
Revisiting the TCA cycle: signaling to tumor formation
Nuno Raimundo et al.
TRENDS IN MOLECULAR MEDICINE (2011)
MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells
E. Lacunza et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Mammary Gland Growth Factors: Roles in Normal Development and in Cancer
Nancy E. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Elena B. Pasquale
NATURE REVIEWS CANCER (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer
Nikolai N. Khodarev et al.
CANCER RESEARCH (2009)
Loss of the SdhB, but not the SdhA subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis
Robert D. Guzy et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
MUC1 oncoprotein blocks glycogen synthase kinase 3β-mediated phosphorylation and degradation of β-catenin
L Huang et al.
CANCER RESEARCH (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation
JA Schroeder et al.
ONCOGENE (2004)
Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization
Y Sawai et al.
JOURNAL OF HEPATOLOGY (2003)
Signaling pathways in mammary gland development
L Hennighausen et al.
DEVELOPMENTAL CELL (2001)
Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation ill the mouse mammary gland
JA Schroeder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
